Article
Abnormal MGMT promoter methylation may contribute to the risk of esophageal cancer: a meta-analysis of cohort studies.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Oct 2014
Zhao Jia-Jun, Li Hong-Yu, Wang Di, Yao Hui, Sun Da-Wei
Abstract excerpt
This meta-analysis was conducted aiming to evaluate the relationship between abnormal O-6-methylguanine-DNA methyltransferase (MGMT) promoter methylation and the risk of esophageal cancer (EC). A range of electronic databases was searched: Web of Science (1945 ~ 2013), the Cochrane Library Databa...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
